CD33 and polycystic ovary syndrome: In this study, CD33 on MDSCs mediated the protective effect of phosphatidylinositol (18:1_18:2) on PCOS, suggesting that enhancing the activity of these cells could mitigate the inflammatory environment typically seen in PCOS.